Retinoid X receptor beta polymorphisms do not explain functional differences in vitamins D and A response in Antineutrophil cytoplasmic antibody associated vasculitis patients

Autoimmunity

Volumn 42, Issue 5, 2009, Pages 467-474

  Kälsch, Anna Isabelle ^a   Peters, Anthea ^a   Buhl, Birgit ^a   Breedijk, Annette ^a   Prem, Katharina ^a   Schmitt, Wilhelm H ^a   Weiss, Christel ^a   Heeringa, Peter ^b   Kallenberg, Cees ^b   Birck, Rainer ^a   Yard, Benito A ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

ANCA associated systemic vasculitis; RXRB; TNF ; Vitamin D

Indexed keywords

INTERLEUKIN 10; LIPOPOLYSACCHARIDE; RETINOIC ACID; RETINOID X RECEPTOR BETA; RETINOL; TUMOR NECROSIS FACTOR ALPHA; VITAMIN D;

ADULT; AGED; ANCA ASSOCIATED VASCULITIS; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; SINGLE NUCLEOTIDE POLYMORPHISM; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; FEMALE; HUMANS; INTERLEUKIN-10; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RETINOID X RECEPTOR BETA; SYSTEMIC VASCULITIS; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA; VITAMIN A; VITAMIN D; YOUNG ADULT;

EID: 70749093001     PISSN: 08916934     EISSN: 1607842X     Source Type: Journal    
DOI: 10.1080/08916930902960347     Document Type: Article

References (29)

1. Tidman M, Olander R, Svalander C, Danielsson D. Patients hospitalized because of small vessel vasculitides with renal involvement in the period 1975-1995: Organ involvement, antineutrophil cytoplasmic antibodies patterns, seasonal attack rates and fluctuation of annual frequencies. J InternMed 1998; 244(2):133-141.
2. Raynauld J, Bloch DA, Fries JF. Seasonal variation in the onset of Wegener's granulomatosis, polyarteritis nodosa and giant cell arteritis. J Rheumatol 1993;20(9):1524-1526.
3. O'Donnell J, Stevanovic VR, Frampton C, Stamp LK, Chapman PT. Wegener's granulomatosis in New Zealand: Evidence for a latitude-dependent incidence gradient. Intern Med J 2007;37(4):242-246.
4. Reinhold-Keller E, Herlyn K, Wagner-Bastmeyer R, Gutfleisch J, Peter HH, Raspe HH, Gross WL. No difference in the incidences of vasculitides between north and south Germany: First results of the German vasculitis register. Rheumatology 2002;41(5):540-549.
5. Jagiello P, Gencik M, Arning L, Wieczorek S, Kunstmann E, Csernok E, Gross WL, Epplen JT. New genomic region for Wegener's granulomatosis as revealed by an extended association screen with 202 apoptosis-related genes. Hum Genet 2004;114(5):468-477.
6. Nieves J, Cosman F, Herbert J, Shen V, Lindsay R. High prevalence of vitamin D deficiency and reduced bone mass in multiple sclerosis. Neurology 1994;44(9):1687-1692.
7. Al-Qadreh A, Voskaki I, Kassiou C, Athanasopoulou H, Sarafidou E, Bartsocas CS. Treatment of osteopenia in children with insulin-dependent diabetes mellitus: The effect of 1 alpha-hydroxyvitamin D3. Eur J Pediatr 1996;155(1): 15-17.
8. Hillman L, Cassidy JT, Johnson L, Lee D, Allen SH. Vitamin D metabolism and bone mineralization in children with juvenile rheumatoid arthritis. J Pediatr 1994;124(6):910-916.
9. Mathieu C, Laureys J, Sobis H, Vandeputte M, Waer M, Bouillon R. 1,25-Dihydroxyvitamin D3 prevents insulitis in NOD mice. Diabetes 1992;41(11):1491-1495.
10. Veldman C, Cantorna MT, DeLuca HF. Expression of 1,25- dihydroxyvitamin D(3) receptor in the immune system. Arch Biochem Biophys 2000;374(2):334-338.
11. Takeuchi A, Reddy GS, Kobayashi T, Okano T, Park J, Sharma S. Nuclear factor of activated T cells (NFAT) as a molecular target for 1alpha,25-dihydroxyvitamin D3- mediated effects. J Immunol 1998;160(1):209-218.
12. Lemire J. Immunomodulatory role of 1,25-dihydroxyvitamin D3. J Cell Biochem 1992;49(1):26-31.
13. Lemire J, Archer DC, Beck L, Spiegelberg HL. Immunosuppressive actions of 1,25-dihydroxyvitamin D3: Preferential inhibition of Th1 functions. J Nutr 1995;125(Suppl. 6): 1704S-1708S.
14. Heine G, Niesner U, Chang HD, Steinmeyer A, Zügel U, Zuberbier T, Radbruch A, Worm M. 1,25-dihydroxyvitamin D(3) promotes IL-10 production in human B cells. Eur J Immunol 2008;38(8):2210-2218.
15. Falk R, Terrell RS, Charles LA, Jennette JC. Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro. Proc Natl Acad Sci USA 1990;87:4115-4119.
16. Kälsch AI, Schmitt WH, Breedijk A, Marinaki S, Weigerding S, Nebe TC, Nemoto K, van derWoude FJ, Yard BA, Birck R. In vivo effects of cyclic administration of 15-deoxyspergualin on leucocyte function in patients with Wegener's granulomatosis. Clin Exp Immunol 2006;146(3):455-462.
17. Deluca H, Cantorna MT. Vitamin D: Its role and uses in immunology. FASEB 2001;15(14):2579-2585.
18. Abe E, Miyaura C, Sakagami H, Takeda M, Konno K, Yamazaki T, Yoshiki S, Suda T. Differentiation of mouse myeloid leukemia cells induced by 1 alpha,25-dihydroxyvitamin D3. Proc Natl Acad Sci USA 1981;78(8):4990-4994. (Pubitemid 12225607)
19. Penna G, Adorini L. 1 Alpha,25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation. J Immunol 2000;164(5):2405-2411.
20. Piemonti L, Monti P, Sironi M, Fraticelli P, Leone BE, Dal Cin E, Allavena P, Di Carlo V. Vitamin D3 affectsdifferentiation, maturation, and function of human monocytederived dendritic cells. J Immunol 2000;164(9):4443-4451.
21. Griffin M, Lutz W, Phan VA, Bachman LA, McKean DJ, Kumar R. Dendritic cell modulation by 1alpha,25 dihydroxyvitamin D3 and its analogs: A vitamin D receptor-dependent pathway that promotes a persistent state of immaturity in vitro and in vivo. Proc Natl Acad Sci USA 2001;98(12): 6800-6805.
22. Hakim I, Bar-Shavit Z. Modulation of TNF-alpha expression in bone marrow macrophages: Involvement of vitamin D response element. J Cell Biochem 2003;88(5):986-998.
23. Prehn J, Fagan DL, Jordan SC, Adams JS. Potentiation of lipopolysaccharide-induced tumor necrosis factor-alpha expression by 1,25-dihydroxyvitamin D3. Blood 1992; 80(11):2811-2816.
24. Sadeghi K, Wessner B, Laggner U, Ploder M, Tamandl D, Friedl J, Zügel U, Steinmeyer A, Pollak A, Roth E, Boltz- Nitulescu G, Spittler A. Vitamin D3 down-regulates monocyte TLR expression and triggers hyporesponsiveness to pathogenassociated molecular patterns. Eur J Immunol 2006; 36(2): 361-370.
25. Giulietti A, van Etten E, Overbergh L, Stoffels K, Bouillon R, Mathieu C. Monocytes from type 2 diabetic patients have a pro-inflammatory profile. 1,25-Dihydroxyvitamin D(3) works as anti-inflammatory. Diabetes Res Clin Pract 2007;77(1): 47-57.
26. Wang X, Allen C, Ballow M. Retinoic acid enhances the production of IL-10 while reducing the synthesis of IL-12 and TNF-alpha from LPS-stimulated monocytes/macrophages. J Clin Immunol 2007;27(2):193-200.
27. Cox S, Arthur P, Kirkwood BR, Yeboah-Antwi K, Riley EM. Vitamin A supplementation increases ratios of proinflammatory to anti-inflammatory cytokine responses in pregnancy and lactation. Clin Exp Immunol 2006;144(3):392-400.
28. Lamprecht P. Off balance: T-cells in antineutrophil cytoplasmic antibody (ANCA)-associated vasculitides. Clin Exp Immunol 2005;141(2):201-210.
29. Sanders J, Stegeman CA, Kallenberg CG. The Th1 and Th2 paradigm in ANCA-associated vasculitis. Kidney Blood Press Res 2003;26:215-220.